Literature DB >> 28315256

Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method.

Catharina Conrad1,2, Miles A Miller3, Jörg W Bartsch4, Uwe Schlomann1, Douglas A Lauffenburger5.   

Abstract

Proteolytic Activity Matrix Analysis (PrAMA) is a method for simultaneously determining the activities of specific Matrix Metalloproteinases (MMPs) and A Disintegrin and Metalloproteinases (ADAMs) in complex biological samples. In mixtures of unknown proteases, PrAMA infers selective metalloproteinase activities by using a panel of moderately specific FRET-based polypeptide protease substrates in parallel, typically monitored by a plate-reader in a 96-well format. Fluorescence measurements are then quantitatively compared to a standard table of catalytic efficiencies measured from purified mixtures of individual metalloproteinases and FRET substrates. Computational inference of specific activities is performed with an easily used Matlab program, which is provided herein. Thus, we describe PrAMA as a combined experimental and mathematical approach to determine real-time metalloproteinase activities, which has previously been applied to live-cell cultures, cellular lysates, cell culture supernatants, and body fluids from patients.

Entities:  

Keywords:  ADAM10; Collagenase; Michaelis-Menten; Multiplexed measurement; Network analysis; Sheddase; Singular value decomposition; TACE

Mesh:

Substances:

Year:  2017        PMID: 28315256     DOI: 10.1007/978-1-4939-6850-3_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis.

Authors:  Catharina Conrad; Kristina Dorzweiler; Miles A Miller; Douglas A Lauffenburger; Herwig Strik; Jörg W Bartsch
Journal:  Fluids Barriers CNS       Date:  2017-08-14

2.  ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.

Authors:  Victor O Oria; Paul Lopatta; Tatjana Schmitz; Bogdan-Tiberius Preca; Alexander Nyström; Catharina Conrad; Jörg W Bartsch; Birte Kulemann; Jens Hoeppner; Jochen Maurer; Peter Bronsert; Oliver Schilling
Journal:  Mol Oncol       Date:  2019-01-09       Impact factor: 6.603

3.  ADAM8 signaling drives neutrophil migration and ARDS severity.

Authors:  Catharina Conrad; Daniela Yildiz; Simon J Cleary; Andreas Margraf; Lena Cook; Uwe Schlomann; Barry Panaretou; Jessica L Bowser; Harry Karmouty-Quintana; Jiwen Li; Nathaniel K Berg; Samuel C Martin; Ahmad Aljohmani; S Farshid Moussavi-Harami; Kristin M Wang; Jennifer J Tian; Mélia Magnen; Colin Valet; Longhui Qiu; Jonathan P Singer; Holger K Eltzschig; Wilhelm Bertrams; Susanne Herold; Norbert Suttorp; Bernd Schmeck; Zachary T Ball; Alexander Zarbock; Mark R Looney; Jörg W Bartsch
Journal:  JCI Insight       Date:  2022-02-08

4.  In Silico and Experimental ADAM17 Kinetic Modeling as Basis for Future Screening System for Modulators.

Authors:  Marian Bienstein; Dmitriy Minond; Ulrich Schwaneberg; Mehdi D Davari; Daniela Yildiz
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.